Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)

Chest

Volumn 132, Issue 3 SUPPL., 2007, Pages 340S-354S

  Cassileth, Barrie R ^a   Deng, Gary E ^a   Gomez, Jorge E ^a   Johnstone, Peter A S ^b   Kumar, Nagi ^c   Vickers, Andrew J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Acupuncture; Botanicals; Cancer; Complementary and alternative medicine; Complementary therapies; Fitness; Herbs; Integrative medicine; Massage therapy; Mind body therapies; Music therapy; Oncology

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUPUNCTURE; ALTERNATIVE MEDICINE; ANXIETY; AYURVEDA; CANCER THERAPY; CHRONIC PAIN; DIET SUPPLEMENTATION; EVIDENCE BASED MEDICINE; EXERCISE; HERBAL MEDICINE; HUMAN; INTEGRATIVE MEDICINE; LUNG CANCER; MASSAGE; MEDITATION; MOOD DISORDER; NEUROPATHY; POSTOPERATIVE PAIN; PRIORITY JOURNAL; REFLEXOLOGY; RELAXATION TRAINING; REVIEW; RISK BENEFIT ANALYSIS; YOGA; ARTICLE; LUNG TUMOR; METHODOLOGY; PAIN; PRACTICE GUIDELINE; SMOKING CESSATION; TREATMENT OUTCOME;

ANXIETY; COMPLEMENTARY THERAPIES; EVIDENCE-BASED MEDICINE; HUMANS; LUNG NEOPLASMS; MOOD DISORDERS; PAIN; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 34848847242     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-1389     Document Type: Article

References (124)

1. Deng G, Cassileth BR, Yeung KS. Complementary therapies for cancer-related symptoms. J Support Oncol 2004; 2:419-429
2. Cassileth BR, Deng G. Complementary and alternative therapies for cancer. Oncologist 2004; 9:80-89
3. Cassileth B, Deng G, Vickers A, et al. PDQ integrative oncology. Hamilton, ON, Canada: BC Decker, 2005
4. Wong R, Sagar S. Acupuncture treatment for chemotherapy-induced peripheral neuropathy: a case series. Acupunct Med 2006; 24:87-91
5. Barnes PM, Powell-Griner E, McFann K, et al. Complementary and alternative medicine use among adults: United States 2002. Adv Data 2004:1-19
6. Adams J, Sibbritt DW, Easthope G, et al. The profile of women who consult alternative health practitioners in Australia. Med J Aust 2003; 179:297-300
7. Chrystal K, Allan S, Forgeson G, et al. The use of complementary/ alternative medicine by cancer patients in a New Zealand regional cancer treatment centre. N Z Med J 2003; 116:U296
8. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280:1569-1575
9. Lee MM, Chang JS, Jacobs B, et al. Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations. Am J Public Health 2002; 92:1606-1609
10. Weiger WA, Smith M, Boon H, et al. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med 2002; 137:889-903
11. Exploring complementary and alternative medicine. In: Medicine IO, ed. The Richard and Hinda Rosenthal lectures 2001. Washington, DC: National Academies Press, 2003
12. Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 1998; 83:777-782
13. Hyodo I, Amano N, Eguchi K, et al. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol 2005; 23:2645-2654
14. Molassiotis A, Fernadez-Ortega P, Pud D, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005; 16:655-663
15. Sovak M, Seligson AL, Konas M, et al. Herbal composition PC-SPES for management of prostate cancer: identification of active principles. J Natl Cancer Inst 2002; 94:1275-1281
16. Beijnen JH, Schellens JH. Drug interactions in oncology. Lancet Oncol 2004; 5:489-496
17. Sparreboom A, Cox MC, Acharya MR, et al. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 2004; 22:2489-2503
18. Albanes D, Heinonen OP, Taylor PR, et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996; 88:1560-1570
19. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers: the Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994;330:1029-1035
20. Wolsko PM, Eisenberg DM, Davis RB, et al. Use of mind-body medical therapies. J Gen Intern Med 2004; 19:43-50
21. Devine EC, Westlake SK. The effects of psychoeducational care provided to adults with cancer: meta-analysis of 116 studies. Oncol Nurs Forum 1995; 22:1369-1381
22. Astin JA. Mind-body therapies for the management of pain. Clin J Pain 2004; 20:27-32
23. Speca M, Carlson LE, Goodey E, et al. A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med 2000; 62:613-622
24. Carlson LE, Speca M, Patel KD, et al. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of Cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology 2004; 29:448-474
25. Cohen L, Warneke C, Fouladi RT, et al. Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer 2004; 100:2253-2260
26. Shapiro SL, Bootzin RR, Figueredo AJ, et al. The efficacy of mindfulness-based stress reduction in the treatment of sleep disturbance in women with breast cancer: an exploratory study. J Psychosom Res 2003; 54:85-91
27. Montgomery GH, Weltz CR, Seltz M, et al. Brief presurgery hypnosis reduces distress and pain in excisional breast biopsy patients. Int J Clin Exp Hypn 2002; 50:17-32
28. Liossi C, Hatira P. Clinical hypnosis versus cognitive behavioral training for pain management with pediatric cancer patients undergoing bone marrow aspirations. Int J Clin Exp Hypn 1999; 47:104-116
29. Faymonville ME, Mambourg PH, Joris J, et al. Psychological approaches during conscious sedation: hypnosis versus stress reducing strategies: a prospective randomized study. Pain 1997; 73:361-367
30. Syrjala KL, Cummings C, Donaldson GW. Hypnosis or cognitive behavioral training for the reduction of pain and nausea during cancer treatment: a controlled clinical trial. Pain 1992; 48:137-146
31. Integration of behavioral and relaxation approaches into the treatment of chronic pain and insomnia: NIH Technology Assessment Panel on Integration of Behavioral and Relaxation Approaches into the Treatment of Chronic Pain and Insomnia. JAMA 1996;276:313-318
32. Zeltzer LK, Dolgin MJ, LeBaron S, et al. A randomized, controlled study of behavioral intervention for chemotherapy distress in children with cancer. Pediatrics 1991; 88:34-42
33. Morrow GR, Morrell C. Behavioral treatment for the anticipatory nausea and vomiting induced by cancer chemotherapy. N Engl J Med 1982; 307:1476-1480
34. Holland JC, Morrow GR, Schmale A, et al. A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. J Clin Oncol 1991; 9:1004-1011
35. Decker TW, Cline-Elsen J, Gallagher M. Relaxation therapy as an adjunct in radiation oncology. J Clin Psychol 1992; 48:388-393
36. Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 1994; 151:1172-1180
37. Cassileth BR. The alternative medicine handbook: the complete reference guide to alternative and complementary therapies. New York, NY: W.W. Norton & Company, 1998
38. Ahles TA, Tope DM, Pinkson B, et al. Massage therapy for patients undergoing autologous bone marrow transplantation. J Pain Symptom Manage 1999; 18:157-163
39. Stephenson NL, Weimich SP, Tavakoli AS. The effects of foot reflexology on anxiety and pain in patients with breast and lung cancer. Oncol Nurs Forum 2000; 27:67-72
40. Grealish L, Lomasney A, Whiteman B. Foot massage: a nursing intervention to modify the distressing symptoms of pain and nausea in patients hospitalized with cancer. Cancer Nurs 2000; 23:237-243
41. Wilkinson S, Aldridge J, Salmon I, et al. An evaluation of aromatherapy massage in palliative care. Palliat Med 1999; 13:409-417
42. Ballard CG, O'Brien JT, Reichelt K, et al. Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa. J Clin Psychiatry 2002; 63:553-558
43. Graham PH, Browne L, Cox H, et al. Inhalation aromatherapy during radiotherapy: results of a placebo-controlled double-blind randomized trial. J Clin Oncol 2003; 21:2372-2376
44. Soden K, Vincent K, Craske S, et al. A randomized controlled trial of aromatherapy massage in a hospice setting. Palliat Med 2004; 18:87-92
45. Gedney JJ, Glover TL, Fillingim RB. Sensory and affective pain discrimination after inhalation of essential oils. Psychosom Med 2004; 66:599-606
46. Cherkin DC, Sherman KJ, Deyo RA, et al. A review of the evidence for the effectiveness, safety, and cost of acupuncture, massage therapy, and spinal manipulation for back pain. Ann Intern Med 2003; 138:898-906
47. Ernst E. The safety of massage therapy. Rheumatology (Oxford) 2003; 42:1101-1106
48. Meltz ML. Radiofrequency exposure and mammalian cell toxicity, genotoxicity, and transformation. Bioelectromagnetics 2003; Suppl 6:S196-S213
49. Elwood JM. Epidemiological studies of radio frequency exposures and human cancer. Bioelectromagneties 2003; Suppl 6:S63-S73
50. Kheifets LI. Electric and magnetic field exposure and brain cancer: a review. Bioelectromagnetics 2001; Suppl 5:S120-S131
51. Han JS. Acupuncture: neuropeptide release produced by electrical stimulation of different frequencies. Trends Neurosci 2003; 26:17-22
52. Wu MT, Hsieh JC, Xiong J, et al. Central nervous pathway for acupuncture stimulation: localization of processing with functional MR imaging of the brain-preliminary experience. Radiology 1999; 212:133-141
53. NIH consensus conference: acupuncture. JAMA 1998; 280: 1518-1524
54. Melchart D, Linde K, Fischer P, et al. Acupuncture for recurrent headaches: a systematic review of randomized controlled trials. Cephalalgia 1999;19:779-786
55. Berman BM, Lao L, Langenberg P, et al. Effectiveness of acupuncture as adjunctive therapy in osteoarthritis of the knee: a randomized, controlled trial. Ann Intern Med 2004; 141:901-910
56. White P, Lewith G, Prescott P, et al. Acupuncture versus placebo for the treatment of chronic mechanical neck pain: a randomized, controlled trial. Ann Intern Med 2004; 141:911-919
57. Manheimer E, White A, Berman B, et al. Meta-analysis: acupuncture for low back pain. Ann Intern Med 2005; 142:651-663
58. Alimi D, Rubino C, Pichard-Leandri E, et al. Analgesic effect of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial. J Clin Oncol 2003; 21:4120-4126
59. Zhang WT, Jin Z, Cui GH, et al. Relations between brain network activation and analgesic effect induced by low vs. high frequency electrical acupoint stimulation in different subjects: a functional magnetic resonance imaging study. Brain Res 2003; 982:168-178
60. Lee A, Done ML. Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev 2004:CD003281
61. Shen J, Wenger N, Glaspy J, et al. Electroacupuncture for control of myeloablative chemotherapy-induced emesis: a randomized controlled trial. JAMA 2000; 284:2755-2761
62. Josefson A, Kreuter M. Acupuncture to reduce nausea during chemotherapy treatment of rheumatic diseases. Rheumatology (Oxford) 2003; 42:1149-1154
63. Streitberger K, Friedrich-Rust M, Bardenhener H, et al. Effect of acupuncture compared with placebo-acupuncture at P6 as additional antiemetic prophylaxis in high-dose chemotherapy and autologous peripheral blood stem cell transplantation: a randomized controlled single-blind trial. Clin Cancer Res 2003; 9:2538-2544
64. Rosen T, de Veciana M, Miller HS, et al. A randomized controlled trial of nerve stimulation for relief of nausea and vomiting in pregnancy. Obstet Gynecol 2003; 102:129-135
65. Streitberger K, Diefenbacher M, Bauer A, et al. Acupuncture compared to placebo-acupuncture for postoperative nausea and vomiting prophylaxis: a randomised placebo-controlled patient and observer blind trial. Anaesthesia 2004; 59:142-149
66. Bertolucci LE, DiDario B. Efficacy of a portable acustimulation device in controlling seasickness. Aviat Space Environ Med 1995; 66:1155-1158
67. Ming JL, Kuo BI, Lin JG, et al. The efficacy of acupressure to prevent nausea and vomiting in post-operative patients. J Adv Nurs 2002; 39:343-351
68. Roscoe JA, Morrow GR, Hickok JT, et al. The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting: a University of Rochester Cancer Center Community Clinical Oncology Program multicenter study. J Pain Symptom Manage 2003;26:731-742
69. White AR, Rampes H, Ernst E. Acupuncture for smoking cessation. Cochrane Database Syst Rev 2002:CD000009
70. Bier ID, Wilson J, Studt P, et al. Auricular acupuncture, education, and smoking cessation: a randomized, sham-controlled trial. Am J Public Health 2002; 92:1642-1647
71. Domino EF, Ni L, Xu Y, et al. Regional cerebral blood flow and plasma nicotine after smoking tobacco cigarettes. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28:319-327
72. Filshie J, Penn K, Ashley S, et al. Acupuncture for the relief of cancer-related breathlessness. Palliat Med 1996; 10:145-150
73. Vickers AJ, Feinstein MB, Deng GE, et al. Acupuncture for dyspnea in advanced cancer: a randomized, placebo-controlled pilot trial. BMC Palliat Care 2005; 4:5
74. Mock V, Atkinson A, Barsevick A, et al. NCCN practice guidelines for cancer-related fatigue. Oncology (Huntingt) 2000; 14:151-161
75. Vickers AJ, Straus DJ, Fearon B, et al. Acupuncture for postchemotherapy fatigue: a phase II study. J Clin Oncol 2004; 22:1731-1735
76. Escalante CP, Grover T, Johnson BA, et al. A fatigue clinic in a comprehensive cancer center: design and experiences. Cancer 2001; 92:1708-1713
77. Shlay JC, Chaloner K, Max MB, et al. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial: Terry Beirn Community Programs for Clinical Research on AIDS. JAMA 1998; 280:1590-1595
78. Abuaisha BB, Costanzi JB, Boulton AJ. Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study. Diabetes Res Clin Pract 1998; 39:115-121
79. Melchart D, Weidenhammer W, Streng A, et al. Prospective investigation of adverse effects of acupuncture in 97 733 patients. Arch Intern Med 2004; 164:104-105
80. Kumar NB, Hopkins K, Allen K, et al. Use of complementary/integrative nutritional therapies during cancer treatment: implications in clinical practice. Cancer Control 2002; 9:236-243
81. Labriola D, Livingston R. Possible interactions between dietary antioxidants and chemotherapy. Oncology (Williston Park) 1999; 13:1003-1008
82. Seifried HE, McDonald SS, Anderson DE, et al. The antioxidant conundrum in cancer. Cancer Res 2003; 63:4295-4298
83. Kumar NB, Allen K, Bell H. Perioperative herbal supplement use in cancer patients: potential implications and recommendations for presurgical screening. Cancer Control 2005; 12:149-157
84. Ko RJ. A U.S. perspective on the adverse reactions from traditional Chinese medicines. J Chin Med Assoc 2004; 67:109-116
85. Cassileth B, Lucarelli C. Herb-drug interactions in oncology. Hamilton, ON, Canada: BC Decker, 2003
86. Cohen I, Tagliaferri M, Tripathy D. Traditional Chinese medicine in the treatment of breast cancer. Semin Oncol 2002; 29:563-574
87. Vickers A. Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials. Cancer Invest 2002; 20:1069-1079
88. Kodama N, Harada N, Nanba H. A polysaccharide, extract from Grifola frondosa, induces Th-1 dominant responses in carcinoma-bearing BALB/c mice. Jpn J Pharmacol 2002; 90:357-360
89. Ooi VE, Liu F. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem 2000; 7:715-729
90. Wasser SP, Weis AL. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol 1999; 19:65-96
91. Taylor JA, Weber W, Standish L, et al. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. JAMA 2003; 290:2824-2830
92. Yale SH, Liu K. Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med 2004; 164:1237-1241
93. Barrett BP, Brown RL, Locken K, et al. Treatment of the common cold with unrefined echinacea: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2002; 137:939-946
94. Geier FP, Konstantinowicz T. Kava treatment in patients with anxiety. Phytother Res 2004; 18:297-300
95. Lehrl S. Clinical efficacy of kava extract WS 1490 in sleep disturbances associated with anxiety disorders: results of a multicenter, randomized, placebo-controlled, double-blind clinical trial. J Affect Disord 2004; 78:101-110
96. Centers for Disease Control and Prevention. Hepatic toxicity possibly associated with kava-containing products: United States, Germany, and Switzerland, 1999-2002; JAMA 2003; 289:36-37
97. Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clin Pharmacol Ther 2004; 76:428-440
98. Linde K, Mulrow CD. St John's wort for depression. Cochrane Database Syst Rev 2000:CD000448
99. Schrader E. Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression. Int Clin Psychopharmacol 2000; 15:61-68
100. Mathijssen RH, Verweij J, de Bruijn P, et al. Effects of St: John's wort on irinotecan metabolism. J Natl Cancer Inst 2002; 94:1247-1249
101. Markowitz JS, Donovan JL, DeVane CL, et al. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 2003; 290:1500-1504
102. Kane GC, Lipsky JJ. Drug-grapefruit juice interactions. Mayo Clin Proc 2000; 75:933-942
103. Bailey DG, Dresser GK. Interactions between grapefruit juice and cardiovascular drugs. Am J Cardiovasc Drugs 2004; 4:281-297
104. Bailey DG, Spence JD, Edgar B, et al. Ethanol enhances the hemodynamic effects of felodipine. Clin Invest Med 1989; 12:357-362
105. Memorial Sloan-Kettering Cancer Center About herbs, botanicals & other products. Available at: http://www.mskcc.org/aboutherbs. Accessed August 7, 2007
106. Vickers A. Alternative cancer cures: "unproven" or "disproven"? CA Cancer J Clin 2004; 54:110-118
107. Creagan ET, Moertel CG, O'Fallon JR, et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer: a controlled trial. N Engl J Med 1979; 301:687-690
108. Moertel CG, Fleming TR, Creagan ET, et al. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy: a randomized double-blind comparison. N Engl J Med 1985; 312:137-141
109. Loprinzi CL, Levitt R, Barton DL, et al. Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial. Cancer 2005; 104:176-182
110. Kosty MP, Fleishman SB, Herndon JE II, et al. Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B. J Clin Oncol 1994; 12:1113-1120
111. Kosty MP, Herndon JE II, Green MR, et al. Placebo-controlled randomized study of hydrazine sulfate in lung cancer. J Clin Oncol 1995; 13:1529-1530
112. Loprinzi CL, Goldberg RM, Su JQ, et al. Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer. J Clin Oncol 1994; 12:1126-1129
113. Loprinzi CL, Kuross SA, O'Fallon JR, et al. Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer. J Clin Oncol 1994; 12:1121-1125
114. Goebell PJ, Otto T, Suhr J, et al. Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial. J Urol 2002; 168:72-75
115. Kleeberg UR, Suciu S, Brocker EB, et al. Final results of the EORTC 18871/DKG 80-1 randomised phase III trial: rIFN-α2b versus rIFN-γ versus ISCADOR M versus observation after surgery in melanoma patients with either high-risk primary (thickness > 3 mm) or regional lymph node metastasis. Eur J Cancer 2004; 40:390-402
116. Lenartz D, Dott U, Menzel J, et al. Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe. Anticancer Res 2000; 20: 2073-2076
117. Steuer-Vogt MK, Bonkowsky V, Ambrosch P, et al. The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial. Eur J Cancer 2001; 37:23-31
118. Evaluation of an unconventional cancer treatment (the Di Bella multitherapy): results of phase II trials in Italy. Italian Study Group for the Di Bella Multitherapy Trails. BMJ 1999; 318:224-228
119. Buiatti E, Arniani S, Verdecchia A, et al. Results from a historical survey of the survival of cancer patients given Di Bella multitherapy. Cancer 1999; 86:2143-2149
120. Buckner JC, Malkin MG, Reed E, et al. Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma. Mayo Clin Proc 1999; 74:137-145
121. Cassileth BR, Lusk EJ, Guerry D, et al. Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy. N Engl J Med 1991; 324:1180-1185
122. Moertel CG, Fleming TR, Rubin J, et al. A clinical trial of amygdalin (Laetrile) in the treatment of human cancer. N Engl J Med 1982; 306:201-206
123. Block JB, Serpick AA, Miller W, et al. Early clinical studies with lapachol (NSC-11905). Cancer Chemother Rep 2 1974; 4:27-28
124. Risberg T, Vickers A, Bremnes RM, et al. Does use of alternative medicine predict survival from cancer? Eur J Cancer 2003; 39:372-377